All In MedTech

PMA device

PASCAL Precision Transcatheter Valve Repair System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

3

Naming "PASCAL Precision"

MAUDE reports

2,050

Brand "PASCAL Precision", since 2015

PubMed studies

14

Mentioning "PASCAL Precision"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing PASCAL Precision Transcatheter Valve Repair System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "PASCAL Precision", any status and sponsor, newest update first.

Open in Trial Radar
  • The CLASP III TR CED StudyNot yet recruiting

    Edwards LifesciencesPublic (EW)

    NCT07859709 · 2,350 participants (planned) · Start Oct 15, 2026 · Primary completion Dec 31, 2030

    Device: PASCAL Precision system Treated · For: Tricuspid Regurgitation; Heart Valve Diseases; Heart Diseases and 2 more

    Sites: Irvine, California

  • Edwards LifesciencesPublic (EW)

    NCT04430075 · 1,000 participants (planned) · Start Aug 23, 2019 · Primary completion Sep 4, 2025

    Device: Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System · For: Mitral Regurgitation; Mitral Insufficiency

    Sites: Vienna, Austria; Bad Krozingen, Germany; Tübingen, Germany · 37 sites in all

  • Edwards LifesciencesPublic (EW)

    NCT04614402 · 300 participants (planned) · Start Jan 15, 2021 · Primary completion Apr 20, 2023

    Device: Edwards PASCAL Transcatheter Valve Repair System; Edwards PASCAL Precision Transcatheter Valve Repair System · For: Tricuspid Valve Insufficiency

    Sites: Tübingen, Germany; Ulm, Germany; München, Germany · 15 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "PASCAL Precision", and for the whole product code for context.

This brand

2,050 reports: 108 malfunction, 1,625 injury, 317 death

Whole product code NPS

2,254 reports: 792 malfunction, 1,379 injury, 81 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "PASCAL Precision"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code NPS.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.